Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species.

Lohith, K. and Kurrey, N. K. and Anu Appaiah, K. A. and Reeta, P. Rao (2019) Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species. mBio, 10 (5). e02307-19.

PDF mBio 2019.pdf - Published Version Restricted to Registered users only Download (3MB) | Request a copy

Abstract

Systemic infections of Candida species pose a significant threat to public health. Toxicity associated with current therapies and emergence of resistant strains present major therapeutic challenges. Here, we report exploitation of the probiotic properties of two novel, food-derived yeasts, Saccharomyces cerevisiae (strain KTP) and Issatchenkia occidentalis (strain ApC), as an alternative approach to combat widespread opportunistic fungal infections. Both yeasts inhibit virulence traits such as adhesion, filamentation, and biofilm formation of several non-albicans Candida species, including Candida tropicalis, Candida krusei, Candida glabrata, and Candida parapsilosis as well as the recently identified multidrug-resistant species Candida auris. They inhibit adhesion to abiotic surfaces as well as cultured colon epithelial cells. Furthermore, probiotic treatment blocks the formation of biofilms of individual nonalbicans Candida strains as well as mixed-culture biofilms of each non-albicans Candida strain in combination with Candida albicans. The probiotic yeasts attenuated non-albicans Candida infections in a live animal. In vivo studies using Caenorhabditis elegans suggest that exposure to probiotic yeasts protects nematodes from infection with non-albicans Candida strains compared to worms that were not exposed to the probiotic yeasts. Furthermore, application of probiotic yeasts postinfection with nonalbicans Candida alleviated pathogenic colonization of the nematode gut. The probiotic properties of these novel yeasts are better than or comparable to those of the commercially available probiotic yeast Saccharomyces boulardii, which was used as a reference strain throughout this study. These results indicate that yeasts derived from food sources could serve as an effective alternative to antifungal therapy against emerging pathogenic Candida species. IMPORTANCE Non-albicans Candida-associated infections have emerged as a major risk factor in the hospitalized and immunecompromised patients. Besides, antifungalassociated complications occur more frequently with these non-albicans Candida species than with C. albicans. Therefore, as an alternative approach to combat these widespread non-albicans Candida-associated infections, here we showed the probiotic effect of two yeasts, Saccharomyces cerevisiae (strain KTP) and Issatchenkia occidentalis (ApC), in preventing adhesion and biofilm formation of five non-albicans Candida strains, Candida tropicalis, Candida krusei, Candida glabrata, Candida parapsilosis, and Candida auris. The result would influence the current trend of the conversion of conventional antimicrobial therapy into beneficial probiotic microbeassociated antimicrobial treatment.

Item Type:	Article
Uncontrolled Keywords:	probiotic yeasts, plastic adhesion assay, Caco-2 cell monolayer, mixedspecies Candida biofilm, Candida tropicalis, Candida krusei, Candida glabrata, Candida parapsilosis, Candida auris, Caenorhabditis elegans, Candida albicans, biofilm
Subjects:	600 Technology > 08 Food technology > 29 Microbiological food > 04 Yeast
Divisions:	Dept. of Biochemistry Fermentation Technology and Bioengineering
Depositing User:	Food Sci. & Technol. Information Services
Date Deposited:	25 Nov 2020 09:02
Last Modified:	25 Nov 2020 09:02
URI:	http://ir.cftri.res.in/id/eprint/14639

Actions (login required)

View Item